Agencourt Genfind? System for DNA Isolation to be Integrated into HPV Test Development FULLERTON, Calif. (July 30, 2008) – Agencourt Bioscience, a wholly owned subsidiary of Beckman Coulter, Inc., today announced that it has entered into a supply agreement with Madison, Wisconsin-based Third Wave Technologies, Inc., a wholly owned subsidiary of Hologic, Inc. Under the […]
SAN DIEGO & ANN ARBOR, Mich.–Sequenom, Inc. (NASDAQ: SQNM – News), a leading provider of molecular diagnostic applications and genetic analysis products and services, and SensiGen LLC, a privately held biotechnology company focused on developing proprietary gene-based, molecular diagnostic tests, today announced expansion of their global alliance to develop and market advanced diagnostic tests and […]
GeneXpert Infinity-48 is the World’s First Fully-Automated Random Access Molecular Diagnostic Testing System; On Display at AACC Meeting SUNNYVALE, Calif., July 29 — Cepheid (Nasdaq: CPHD – News) today introduced its GeneXpert® Infinity-48 high-throughput system at the 2008 American Association for Clinical Chemistry Annual Meeting in Washington, D.C. The newest addition to Cepheid’s GeneXpert family […]
WASHINGTON, D.C. (July 29, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science, will exhibit a new spectrophotometer that offers unique benefits for human leukocyte antigen (HLA) typing laboratories dealing with donor tissue matching. The Thermo Scientific NanoDrop™ 1000 represents the growing trend of successful genome research tools finding their way to […]
Mexican Ministry of Health Selects PerkinElmer to Support Screening Program Expansion WALTHAM, Mass.–PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced a one-year agreement with the Mexican Ministry of Health, la Secretaría de Salud, to expand its newborn screening program across Mexico. Under the terms of the agreement, PerkinElmer will […]
ALAMEDA, Calif.–Celera (NASDAQ:CRA) today announced that it has received marketing clearance from the U.S. Food and Drug Administration for its 510(k) submission of the ViroSeq HIV-1 Genotyping System Software v2.8. The ViroSeq HIV-1 Genotyping™ System is designed to detect mutations in the HIV-1 viral genome that confer drug resistance, and as such, is used as […]
Patent Family Comprises Complementary Technologies That Enable Predictive Whole Genome Association Studies MOUNTAIN VIEW, Calif.–Perlegen Sciences, Inc., a molecular diagnostics company focused on the discovery and commercialization of clinically important human genetic variation, announced today the opening of its portfolio of patented technologies that together enable whole genome association studies capable of assessing an individual’s […]
AUSTIN, Texas & ROTTERDAM, Netherlands–Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, and ViroNovative BV today announced that the companies have signed a licensing agreement that gives Luminex worldwide rights to use ViroNovative’s human metapneumovirus (hMPV) intellectual property in the xTAG Respiratory Viral Panel (RVP). Under the terms of the agreement, rights to […]
HER2 Gene Amplification Test Will Aid in Assessing Breast Cancer Patient Candidacy for Herceptin(R) Treatment CARLSBAD, Calif.–Invitrogen Corporation, (NASDAQ:IVGN – News), a provider of essential life science technologies for research, production and diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its SPOT-Light® HER2 CISH Kit, indicated as […]
Reagent Kits Will Strengthen Affymetrix’ Diagnostic Product Portfolio SANTA CLARA, Calif. & AUSTIN, Texas–Affymetrix Inc. (NASDAQ:AFFX – News) and Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to license, develop and manufacture in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications. The new IVT reagent kits […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
